Patents by Inventor Birgitta Olofsson

Birgitta Olofsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Processed vascular endothelial growth factor-B polypeptides
    Patent number: 7341996
    Abstract: VEGF-B polypeptides from the PDGF family of growth factors having the property of promoting mitosis and proliferation of vascular endothelial cells, DNA sequences encoding these polypeptides, pharmaceutical compositions containing them and antibodies which react with them. The VEGF-B polypeptides are useful in stimulating angiogenesis as well as in diagnostic applications.
    Type: Grant
    Filed: September 24, 2004
    Date of Patent: March 11, 2008
    Assignees: Ludwig Institute for Cancer Research, Licentia Ltd.
    Inventors: Ulf Eriksson, Birgitta Olofsson, Kari Alitalo, Katri Pajusola
  • Antibodies specific for vascular endothelial growth factor-B and DNA coding therefor
    Publication number: 20050064493
    Abstract: VEGF-B polypeptides from the PDGF family of growth factors having the property of promoting mitosis and proliferation of vascular endothelial cells, DNA sequences encoding these polypeptides, pharmaceutical compositions containing them and antibodies which react with them. The VEGF-B polypeptides are useful in stimulating angiogenesis as well as in diagnostic applications.
    Type: Application
    Filed: September 24, 2004
    Publication date: March 24, 2005
    Applicant: LICENTIA LTD.
    Inventors: Ulf Eriksson, Birgitta Olofsson, Kari Alitalo, Katri Pajusola
  • Vascular endothelial growth factor-B and DNA coding therefor
    Publication number: 20030170253
    Abstract: VEGF-B polypeptides from the PDGF family of growth factors having the property of promoting mitosis and proliferation of vascular endothelial cells, DNA sequences encoding these polypeptides, pharmaceutical compositions containing them and antibodies which react with them. The VEGF-B polypeptides are useful in stimulating angiogenesis as well as in diagnostic applications.
    Type: Application
    Filed: September 25, 2001
    Publication date: September 11, 2003
    Applicant: HELSINKI UNIVERSITY LICENSING, LTD.
    Inventors: Ulf Eriksson, Birgitta Olofsson, Kari Alitalo, Katri Pajusola
  • Neuropilin/growth factor complexes and uses thereof
    Patent number: 6515105
    Abstract: Complexes of a protein selected from the group consisting of VEGF-B167, VEGF-C, VEGF-D and processed VEGF-B186 and analogs thereof and the neuropilin-1 (NP-1) receptor, the extracellular domain or a ligand-binding fragment or analogue thereof; the use of such complexes in assays for growth factor proteins having substantially the same binding affinity for a cell surface receptor as VEGF-B167, VEGF-C, VEGF-D or processed VEGF-B186 and/or in promoting or antagonizing a cellular response mediated by VEGF-B167, VEGF-C, VEGF-D and/or processed VEGF-B186; and specific binding partners, e.g. antibodies, for such complexes.
    Type: Grant
    Filed: October 19, 1999
    Date of Patent: February 4, 2003
    Assignees: Licentia Ltd., Ludwig Institute for Cancer Research
    Inventors: Kari Alitalo, Ulf Eriksson, Birgitta Olofsson, Taija Makinen
  • Glycosylated VEGF-B and method for increasing the amount of soluble VEGF-B
    Publication number: 20020068694
    Abstract: N-glycosylated VEGF-B proteins, nucleic molecule encoding these proteins, pharmaceutical compositions containing them and a method for increasing the amount of a soluble VEGF-B protein. The VEGF-B proteins are useful in stimulating and maintaining angiogenesis.
    Type: Application
    Filed: July 26, 2001
    Publication date: June 6, 2002
    Inventors: Markku Michael Jeltsch, Kari Alitalo, Birgitta Olofsson, Ulf Eriksson
  • Antibodies specific for vascular endothelial growth factor-B
    Patent number: 6331301
    Abstract: VEGF-B polypeptides from the PDGF family of growth factors having the property of promoting mitosis and proliferation of vascular endothelial cells, DNA sequences encoding these polypeptides, pharmaceutical compositions containing them and antibodies which react with them. The VEGF-B polypeptides are useful in stimulating angiogenesis as well as in diagnostic applications.
    Type: Grant
    Filed: May 6, 1997
    Date of Patent: December 18, 2001
    Assignees: Ludwig Institute for Cancer Research, Helsinki University Licensing Ltd. Oy
    Inventors: Ulf Eriksson, Birgitta Olofsson, Kari Alitalo, Katri Pajusola
  • Vascular endothelial growth factor-b and dna coding therefor
    Patent number: 5928939
    Abstract: VEGF-B polypeptides from the PDGF family of growth factors having the property of promoting mitosis and proliferation of vascular endothelial cells, DNA sequences encoding these polypeptides, pharmaceutical compositions containing them and antibodies which react with them. The VEGF-B polypeptides are useful in stimulating angiogenesis as well as in diagnostic applications.
    Type: Grant
    Filed: December 6, 1995
    Date of Patent: July 27, 1999
    Assignee: Ludwig Institute For Cancer Research
    Inventors: Ulf Eriksson, Birgitta Olofsson, Kari Alitalo, Katri Pajusola
  • Vascular endothelial growth factor-B
    Patent number: 5840693
    Abstract: VEGF-B polypeptides from the PDGF family of growth factors having the property of promoting mitosis and proliferation of vascular endothelial cells, DNA sequences encoding these polypeptides, pharmaceutical compositions containing them and antibodies which react with them. The VEGF-B polypeptides are useful in stimulating angiogenesis as well as in diagnostic applications.
    Type: Grant
    Filed: March 1, 1996
    Date of Patent: November 24, 1998
    Assignees: Ludwig Institute for Cancer Research, Helsinki University Licensing Ltd. Oy
    Inventors: Ulf Eriksson, Birgitta Olofsson, Kari Alitalo, Katri Pajusola
  • Vascular endothelial growth factor-B and DNA coding therefor
    Patent number: 5607918
    Abstract: VEGF-B polypeptides from the PDGF family of growth factors having the property of promoting mitosis and proliferation of vascular endothelial cells, DNA sequences encoding these polypeptides, pharmaceutical compositions containing them and antibodies which react with them. The VEGF-B polypeptides are useful in stimulating angiogenesis as well as in diagnostic applications.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: March 4, 1997
    Assignees: Ludwig Institute for Cancer Research, Helsinki University Licensing Ltd. Oy
    Inventors: Ulf Eriksson, Birgitta Olofsson, Kari Alitalo, Katri Pajusola